Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?
| ZLAB Stock | USD 26.63 0.63 2.42% |
About 55% of Zai Lab's investors are presently thinking to get in. The analysis of overall sentiment of trading Zai Lab stock suggests that some investors are interested at this time. The current market sentiment, together with Zai Lab's historical and current headlines, can help investors time the market. In addition, many technical investors use Zai Lab stock news signals to limit their universe of possible portfolio assets.
Zai |
The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a very long time. Novocure and its international partner Zai Lab announced successful top-line results from the Panova-3 study on Dec. 2, 2024. In a nutshell, it showed that the companys electric field-generating devices can improve pancreatic cancer patients odds of survival.
Read at finance.yahoo.com
 |
Zai Lab Fundamental Analysis
We analyze Zai Lab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zai Lab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zai Lab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Zai Lab is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Zai Lab Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zai Lab stock to make a market-neutral strategy. Peer analysis of Zai Lab could also be used in its relative valuation, which is a method of valuing Zai Lab by comparing valuation metrics with similar companies.
Peers
Zai Lab Related Equities
| LEGN | Legend Biotech | 7.99 | ||||
| MDGL | Madrigal Pharmaceuticals | 5.74 | ||||
| ERAS | Erasca | 1.58 | ||||
| KRYS | Krystal Biotech | 1.26 | ||||
| CGEM | Cullinan Oncology | 0.86 | ||||
| APLS | Apellis Pharmaceuticals | 0.86 | ||||
| ALNY | Alnylam Pharmaceuticals | 0.58 | ||||
| PTCT | PTC Therapeutics | 0.38 | ||||
| BPMC | Blueprint Medicines | 0.79 | ||||
| ROIV | Roivant Sciences | 0.98 | ||||
| AKRO | Akero Therapeutics | 2.27 | ||||
| CCCC | C4 Therapeutics | 3.64 | ||||
| ASND | Ascendis Pharma | 4.00 |
Complementary Tools for Zai Stock analysis
When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |